Filing Flows › Biomerica (BMRA) › Clinical Lab revenue
Biomerica (BMRA) Clinical Lab revenue by quarter
Biomerica's Clinical Lab revenue was $775K in Q1 FY27 (first quarter fiscal 2027), +89% from Q4 FY26. Over the last 6 quarters it ranged from $411K (Q4 FY26) to $1.0M (Q1 FY26).
| Quarter | Clinical Lab revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $775K | +89% | -24% |
| Q4 FY26 | $411K | -34% | — |
| Q3 FY26 | $621K | -8% | -1% |
| Q2 FY26 | $676K | -34% | — |
| Q1 FY26 | $1.0M | +63% | — |
| Q3 FY25 | $627K | — | — |
Q1 FY27 at a glance
Biomerica, Q1 FY27: revenue $1.3M (-8% year over year), operating margin -97.0%, net loss $1.2M, operating cash flow −$802K. The chart follows the revenue to costs, profit and cash.
Questions
What is Biomerica's Clinical Lab revenue?
Biomerica's Clinical Lab revenue was $775K in Q1 FY27 (first quarter fiscal 2027), +89% from Q4 FY26.
How has Biomerica's Clinical Lab revenue changed?
Over the last 6 quarters it ranged from $411K (Q4 FY26) to $1.0M (Q1 FY26).